Volume 67, Issue 6, Pages (June 2005)

Slides:



Advertisements
Similar presentations
Fig. 2. Effects of lobeglitazone on profibrotic gene expression in kidneys of unilateral ureteral obstruction (UUO) mice. (A) Representative Western blot.
Advertisements

Volume 77, Issue 6, Pages (March 2010)
Volume 78, Issue 3, Pages (August 2010)
Volume 54, Issue 5, Pages (November 1998)
Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor- β1 expression in acute ureteral obstruction  Gyu-Tae Shin, Wook-Hwan.
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 78, Issue 4, Pages (August 2010)
Volume 82, Issue 6, Pages (September 2012)
David J. Nikolic-Paterson, Shuang Wang, Hui Yao Lan 
Volume 71, Issue 3, Pages (February 2007)
Volume 67, Issue 3, Pages (March 2005)
Volume 84, Issue 2, Pages (August 2013)
Volume 68, Issue 6, Pages (December 2005)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
c-myc antisense oligonucleotide treatment ameliorates murine ARPKD
Volume 86, Issue 3, Pages (September 2014)
Volume 69, Issue 10, Pages (May 2006)
Volume 88, Issue 3, Pages (September 2015)
Volume 58, Issue 6, Pages (December 2000)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Kameswaran Surendran, Theodore C. Simon, Helen Liapis, John K. McGuire 
Volume 61, Issue 1, Pages (January 2002)
Volume 67, Issue 4, Pages (April 2005)
Volume 58, Issue 2, Pages (August 2000)
Volume 56, Issue 3, Pages (September 1999)
Volume 80, Issue 10, Pages (November 2011)
Volume 61, Issue 5, Pages (May 2002)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 84, Issue 2, Pages (August 2013)
Volume 84, Issue 5, Pages (November 2013)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 81, Issue 5, Pages (March 2012)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 60, Issue 2, Pages (August 2001)
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Volume 57, Issue 3, Pages (March 2000)
Volume 70, Issue 10, Pages (November 2006)
Volume 61, Issue 6, Pages (June 2002)
Volume 86, Issue 4, Pages (October 2014)
Volume 127, Issue 3, Pages (September 2004)
Volume 92, Issue 3, Pages (September 2017)
Volume 61, Issue 6, Pages (June 2002)
Volume 63, Issue 4, Pages (April 2003)
Volume 64, Issue 3, Pages (September 2003)
Volume 76, Issue 5, Pages (September 2009)
Volume 55, Issue 3, Pages (March 1999)
Caspase-3 and apoptosis in experimental chronic renal scarring
Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.
Volume 85, Issue 2, Pages (January 2014)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Volume 78, Issue 7, Pages (October 2010)
Volume 82, Issue 2, Pages (July 2012)
Volume 82, Issue 3, Pages (August 2012)
Volume 56, Issue 2, Pages (August 1999)
Volume 57, Issue 1, Pages (January 2000)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 65, Issue 6, Pages (June 2004)
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
Volume 54, Issue 1, Pages (July 1998)
Volume 60, Issue 5, Pages (November 2001)
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Volume 58, Issue 5, Pages (November 2000)
Volume 59, Issue 6, Pages (June 2001)
c-myc antisense oligonucleotide treatment ameliorates murine ARPKD
Volume 21, Issue 2, Pages (February 2013)
Volume 75, Issue 8, Pages (April 2009)
Volume 70, Issue 9, Pages (November 2006)
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 65, Issue 1, Pages (January 2004)
Presentation transcript:

Volume 67, Issue 6, Pages 2221-2238 (June 2005) Multifunctionality of PAI-1 in fibrogenesis: Evidence from obstructive nephropathy in PAI- 1–overexpressing mice  Shunya Matsuo, JeseS M. Lepez-Guisa, Xiaohe Cai, Daryl M. Okamura, Charles E. Alpers, Roger E. Bumgarner, Mette A. Peters, Guoqiang Zhang, Allison A. Eddy  Kidney International  Volume 67, Issue 6, Pages 2221-2238 (June 2005) DOI: 10.1111/j.1523-1755.2005.00327.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Hepatic plaminogen activator inhibitor 1 (PAI-1) mRNA levels are higher in PAI-1 tg mice. The upper autoradiograph is a Northern blot of hepatic PAI-1 RNA isolated from mice on day 7 unilateral ureteral obstruction (UUO). Shown below each lane is the corresponding ethidium bromide–stained 18s ribosome band. The graph represents the results of PAI-1 band density measurements expressed as mean fold increase ± 1 SD. #P < 0.05 compared with PAI-1 wild-type (WT) group. Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Kidney plasminogen activator inhibitor-1 (PAI-1) expression levels are higher in PAI-1 tg mice after unilateral ureteral obstruction (UUO). (A) PAI-1 mRNA. A representative PAI-1 Northern blot autoradiograph illustrates renal mRNA levels with 28s ribosome bands below each lane. The graph summarizes the results of band density measurements (N = 6/group) expressed as mean fold increase ± 1 SD. #P < 0.05 compared with PAI-1 wild-type (WT) group at the same time point. PAI-1 mRNA was not detectable in either sham group. (B) PAI-1 protein. A representative Western blot illustrates the 50 kD PAI-1 protein in PAI-1 tg mice from 3 days onward, and in the wild-type mice beginning on day 7. The graph summarizes the results of band density measurements (N = 6/group) expressed as mean fold increase ± 1 SD. #P < 0.05 compared with PAI-1 wild-type group at the same time point. By immunostaining PAI-1 protein was strongly expressed in renal tubules but also within the interstitium (day 14 shown). In general staining intensity was greater in the PAI-1 tg mice (A) compared to PAI-1 WT mice (B) (magnification ×400). Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Total kidney collagen levels are significantly higher in plasminogen activator inhibitor (PAI-1) tg mice. Results are expressed as mean ± 1 SD. The symbols are: (▪) PAI-1tg mice; (□) PAI-1 wild-type (WT) mice. #P < 0.05 compared to PAI-1 WT group at the same time point; *P < 0.05 compared to sham group of same genotype. Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Interstitial fibrosis severity is worse in plasminogen activator inhibitor (PAI-1) tg mice. (A) Graph illustrates the mean tubulointerstitial area occupied by collagen fibrils reactive with sirius red, expressed as mean% area ± 1 SD. The symbols are: (▪) PAI-1 tg mice; □) PAI-1 wild-type (WT) mice. #P < 0.05 compared with PAI-1 wild-type group at the same time point; *P < 0.05 compared to sham group of same genotype. (B) Representative sirius red photomicrographs. Panels A to D are PAI-1 tg mice that were sham-operated, and after 3, 7, and 14 days of unilateral ureteral obstruction (UUO), respectively. Panels E to H are PAI-1 wild-type sham, 3, 7, and 14 days UUO, respectively (magnification 400×). Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Plasminogen gel zymogram demonstrates delayed effects of plasminogen activator inhibitor-1 (PAI-1) expression levels on renal urokinase-type plasmin activity (uPA). A representative zymogram illustrates plasminogen lytic activity of the 40 kD uPA protein. The graph shows the mean activity ± 1 SD. Symbols are: (▪) PAI-1 tg mice; (□) PAI-1 wild-type (WT) mice. #P < 0.05 compared with PAI-1 wild-type group at same time point; *P < 0.05 compared to sham group of same genotype. Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Interstitial macrophage numbers are higher in plasminogen activator inhibitor-1 (PAI-1) tg mice. (A) The graph summarizes the number of F4/80-positive interstitial macrophages per 400× field expressed as mean number per field ± 1 SD. #P < 0.05 compared with PAI-1 wild-type (WT) group at same time point; *P < 0.05 compared to sham group of same genotype. (B) Representative F4/80 immunohistochemical photomicrographs are PAI-1 tg sham, 3, 7, and 14 days UUO, panels A to D, respectively, and PAI-1 wild-type sham, 3, 7, and 14 days UUO, panels E to H, respectively (magnification ×400). Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Renal interstitial myofibroblasts appear faster in plasminogen activator inhibitor-1 (PAI-1) tg mice. (A) The graph summarizes the density of the α-smooth muscle actin (α-SMA)–positive interstitial myofibroblasts expressed as mean% positive area ± 1 SD. #P < 0.05 compared with PAI-1 wild-type (WT) group at same time point; *P < 0.05 compared to sham group of same genotype. (B) Representative α-SMA immunohistochemical photomicrographs are PAI-1 tg sham, 3, 7, and 14 days UUO, panels A to D, respectively, and PAI-1 wild-type sham, 3, 7, and 14 days UUO, panels E to H, respectively (magnification ×400). Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Renal loss of E-cadherin occurs more rapidly in plasminogen activator inhibitor-1 (PAI-1) tg mice. The upper Western blot illustrates the changes in E-cadherin protein levels (126 kD) on 14 days' unilateral ureteral obstruction (UUO). Ponceau S staining shown below demonstrates the equivalency of protein loading and transfer. The graph summarizes the results of single band density measurements (N = 6/group/time point) expressed as mean fold increase ± 1 SD. Symbols are: (▪) PAI-1 tg mice; (□) PAI-1 wild-type (WT) mice. #P < 0.05 compared with PAI-1 wild-type group at same time point; *P < 0.05 compared with sham group of same genotype. Below, light photomicrographs of E-cadherin immunostaining are PAI-1 tg mice (A) and PAI-1 wild-type mice (C) in sham-operated group and PAI-1 tg mice (B) and PAI-1 wild-type mice (D) from the 14 days' UUO group (magnification ×400). Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Renal loss of Ksp-cadherin occurs more rapidly in plasminogen activator inhibitor (PAI-1) tg mice. The upper Western blots demonstrate a time-dependent alteration in Ksp-cadherin (130 kD) expression. Ponceau S staining shown in the lower portion illustrates the equivalency of protein loading and transfer. The graph summarizes the results of single band density measurements expressed as mean fold increase ± 1 SD. Symbols are: (▪) PAI-1 tg mice; □) PAI-1 wild-type (WT) mice. #P < 0.05 compared with PAI-1 wild-type group at same time point; *P < 0.05 compared with sham group of same genotype. Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 Renal transforming growth factor-β (TGF-β) and α1(I) procollagen mRNA levels are higher in plasminogen activator inhibitor (PAI-1) tg mice. The autoradiographs of TGF-β (A) and α1(I) procollagen (B) are the Northern blots with 18s ribosome bands shows below each lane. The graphs summarize the results of each band density measurements (N = 6) expressed as mean fold increase ± 1 SD. #P < 0.05 compared with PAI-1 wild-type (WT) group at same time point; *P < 0.05 compared with sham group of same genotype. Kidney International 2005 67, 2221-2238DOI: (10.1111/j.1523-1755.2005.00327.x) Copyright © 2005 International Society of Nephrology Terms and Conditions